(19)
(11) EP 2 790 714 A2

(12)

(88) Date of publication A3:
31.10.2013

(43) Date of publication:
22.10.2014 Bulletin 2014/43

(21) Application number: 12858180.8

(22) Date of filing: 17.12.2012
(51) International Patent Classification (IPC): 
A61K 38/02(2006.01)
A61P 27/02(2006.01)
 C07K 14/58(2006.01)
A61P 27/10(2006.01)
(86) International application number:
PCT/US2012/070190
(87) International publication number:
WO 2013/090931 (20.06.2013 Gazette 2013/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.12.2011 US 201161576720 P

(71) Applicant: Kalos Therapeutics, Inc.
San Diego, CA 92122 (US)

(72) Inventor:
  • The designation of the inventor has not yet been filed
     ()

(74) Representative: Vossius & Partner 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) METHODS AND USES OF ANP (ATRIAL NATRIURETIC PEPTIDE), BNP (BRAIN NATRIURETIC PEPTIDE) AND CNP (C-TYPE NATRIURETIC PEPTIDE)-RELATED PEPTIDES AND DERIVATIVES THEREOF FOR TREATMENT OF RETINAL DISORDERS AND DISEASES